TrialCirculation2021

Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.

Gregory G Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.